These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis. Tulassay T, Tulassay Z, Büki B, Szathmári M, Rascher W. Acta Med Hung; 1988 Jan; 45(1):73-81. PubMed ID: 2970621 [Abstract] [Full Text] [Related]
51. DOCA test for aldosteronism: its usefulness and implications. Rodríguez JA, Lopez JM, Biglieri EG. Hypertension; 1981 Jan; 3(6 Pt 2):II-102-6. PubMed ID: 7028610 [Abstract] [Full Text] [Related]
52. Increase of plasma atrial natriuretic peptide levels after sublingual administration of nifedipine in essentially hypertensive patients. Rappelli A, Dessì-Fulgheri P, Bandiera F, Di Noto G. Int J Cardiol; 1989 Jan; 25 Suppl 1():S25-8. PubMed ID: 2533582 [Abstract] [Full Text] [Related]
53. Effects of human atrial natriuretic peptide on renal function and vasopressin release. Kimura T, Abe K, Shoji M, Tsunoda K, Matsui K, Ota K, Inoue M, Yasujima M, Yoshinaga K. Am J Physiol; 1986 May; 250(5 Pt 2):R789-94. PubMed ID: 2939732 [Abstract] [Full Text] [Related]
60. Atrial natriuretic peptide administration to normal and salt depleted rats--effects on digoxin-like immunoreactive factor, aldosterone, ACTH, and renal function. Shilo L, Pomeranz A, Rathaus M, Weiss E, Bernheim J, Shenkman L. Life Sci; 1988 Aug; 42(19):1855-9. PubMed ID: 2835565 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]